17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2

INTRODUCTION: 17-allyamino-17-demethoxygeldanamycin (17-AAG), a small molecule inhibitor of Hsp90, is currently in clinical trials in breast cancer. However, 17-AAG treatment often results in inhibition of tumor growth rather than shrinkage, making detection of response a challenge. Magnetic resonan...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandes, Alissa H, Ward, Christopher S, Ronen, Sabrina M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096977/
https://www.ncbi.nlm.nih.gov/pubmed/20946630
http://dx.doi.org/10.1186/bcr2729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096977/
https://www.ncbi.nlm.nih.gov/pubmed/20946630
http://dx.doi.org/10.1186/bcr2729

Ejemplares similares